Nautilus Biotechnology Inc

NAS:NAUT (USA)   Ordinary Shares
$ 1.73 +0.01 (+0.58%) 11:08 PM EST
At Loss
P/B:
0.97
Market Cap:
$ 217.23M
Enterprise V:
$ 108.18M
Volume:
98.35K
Avg Vol (2M):
144.96K
Trade In:
Volume:
98.35K
At Loss
Avg Vol (2M):
144.96K

Business Description

Nautilus Biotechnology Inc
NAICS : 541714 SIC : 2834
ISIN : US63909J1088

Share Class Description:

NAUT: Ordinary Shares
Description
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
Name Current Vs Industry Vs History
Cash-To-Debt 4.45
Equity-to-Asset 0.86
Debt-to-Equity 0.14
Debt-to-EBITDA -0.42
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 18.87
9-Day RSI 25.79
14-Day RSI 30.18
6-1 Month Momentum % 7.14
12-1 Month Momentum % -27.49

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.65
Quick Ratio 16.65
Cash Ratio 16.23

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.3
Shareholder Yield % 0.84
Name Current Vs Industry Vs History
ROE % -28.07
ROA % -24.29
ROIC % -66.45
ROC (Joel Greenblatt) % -226.62
ROCE % -29.1

Financials (Next Earnings Date:2025-02-28 Est.)

NAUT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NAUT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Nautilus Biotechnology Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.56
Beta 1.2
Volatility % 37.58
14-Day RSI 30.18
14-Day ATR ($) 0.151008
20-Day SMA ($) 2.03325
12-1 Month Momentum % -27.49
52-Week Range ($) 1.65 - 3.4547
Shares Outstanding (Mil) 125.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nautilus Biotechnology Inc Filings

Filing Date Document Date Form
No Filing Data

Nautilus Biotechnology Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Nautilus Biotechnology Inc Frequently Asked Questions

What is Nautilus Biotechnology Inc(NAUT)'s stock price today?
The current price of NAUT is $1.73. The 52 week high of NAUT is $3.45 and 52 week low is $1.65.
When is next earnings date of Nautilus Biotechnology Inc(NAUT)?
The next earnings date of Nautilus Biotechnology Inc(NAUT) is 2025-02-28 Est..
Does Nautilus Biotechnology Inc(NAUT) pay dividends? If so, how much?
Nautilus Biotechnology Inc(NAUT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1